By bridging fundamental molecular biology with translational nutritional science, natural PCSK9 modulators offer promising strategies to complement pharmatherapy, potentially increasing the accessibility of PCSK9-targeted therapies to broader populations and addressing the growing global burden of cardiovascular diseases. Here, PCSK9 is linked to cardiovascular disorder.